鲁索替尼乳膏在中国上市了吗?好购买吗？

Introduction: Ruxolitinib cream is a topical, selective Janus kinase (JAK) inhibitor approved by the FDA for the short-term, non-sustained treatment of mild to moderate atopic dermatitis in non-immunocompromised (patients with uncompromised immune systems) adults and pediatric patients 12 years and older whose condition cannot be adequately controlled by topical prescription therapies or who are inappropriate for these therapies.

Is ruxolitinib cream available in China?

It is not currently available in most parts of China, but it has been launched in China’s Greater Bay Area and Macau to treat patients with vitiligo aged 12 years and above.

On April 11, 2024, ruxolitinib cream was approved by the Macau Government's Drug Administration (ISAF) for new drug marketing application, and subsequently passed the "Hong Kong and Macao Drug and Device Clearance" policy, and obtained the Guangdong Provincial Drug License on August 19. Approved by the Food and Drug Administration, it has been officially launched in designated medical institutions in the Guangdong-Hong Kong-Macao Greater Bay Area for the treatment of non-segmental vitiligo with facial involvement in adolescent and adult patients aged 12 and above, providing a new treatment option for patients with related indications.

Is ruxolitinib cream easy to buy?

Although ruxolitinib cream is not available in most parts of China, patients can still purchase this drug through several formal channels. Patients can refer to the following.

1. Hospital pharmacy: After visiting a hospital in an area where ruxolitinib cream is listed, patients can purchase the drug directly in the hospital pharmacy.

2. Pharmacies: Ruxolitinib cream can also be purchased in pharmacies in areas where it is marketed. A medical prescription is required before purchase.

3. Medical service institutions: Whether you want to buy the original version of ruxolitinib cream or the generic version, you can get it through medical service institutions.

4. Participation in clinical trials: For patients who meet the clinical trial conditions, participating in clinical trials of ruxolitinib cream is also a possible way to obtain it. It not only allows patients to use new drugs that have not yet been launched in advance, but also helps promote the drug development process and accumulate clinical experience.

When purchasing ruxolitinib cream, patients should carefully choose the purchasing channel to ensure the quality and legality of the drug purchased. It is best to purchase under the guidance of a professional doctor and avoid buying fake and inferior drugs. At the same time, understand the usage and precautions of the drug to ensure its safety and effectiveness during use.

How to use Ruxolitinib Cream

Ruxolitinib Cream is applied directly to the affected area of ​​skin in the form of a film, twice daily, covering up to 20% of the body surface area, for up to 8 weeks. Massage the cream gently until fully absorbed, taking care not to apply it on healthy skin to avoid unnecessary irritation. The 60g tubes should not be used more than once per week and the 100g tubes should not be used more than once every two weeks. Ruxolitinib Cream is for topical use only and is not intended for ophthalmic, oral, or intravaginal administration.

During use of ruxolitinib cream, contact with the eyes, mouth, and other mucous membranes should be avoided. In case of accidental contact, rinse immediately with plenty of water. Additionally, pregnant or breastfeeding women should consult a physician before use.